AdAlta Limited (ASX:1AD) Advances ‘East to West’ Immunotherapy Strategy
AdAlta Limited (ASX:1AD) accelerates its ‘East to West’ cellular immunotherapy strategy, signing additional term sheets to enhance pipeline growth.
The Hub of Australian Finance News
AdAlta Limited (ASX:1AD) accelerates its ‘East to West’ cellular immunotherapy strategy, signing additional term sheets to enhance pipeline growth.
Magellan Financial Group Ltd (ASX:MFG) reports total funds under management of A$39.1 billion as of 31 January 2025, highlighting growth in institutional funds.
Cullen Resources (ASX:CUL) announces significant new gold anomalies in Yardilla Project, highlighting prospects Lila, Cleanthes, Lila West, and Ten Mile Rocks.
Pure Hydrogen Corporation Limited (ASX: PH2) successfully delivers Australia’s first hydrogen fuel cell rear loader to Solo Resource Recovery, advancing the clean energy transition.
Novo Resources Corp (ASX:NVO) strengthens its Australian exploration portfolio with new joint ventures and reports a strong financial position in Q4 2024.
Warriedar Resources (ASX:WA8) reports significant gold intercepts from Q4 2024 drilling, highlighting growth potential at Golden Range Project.
West African Resources (ASX:WAF) completes maiden grade control drilling at Kiaka, anticipating first gold in Q3 2025.
Benz Mining Corp (ASX:BNZ) launches its maiden drill program at Glenburgh, targeting high-grade gold extensions to enhance resource growth.
Midway Limited (ASX:MWY) suspends trading following a scheme of arrangement where River Capital acquires all issued shares.
Eumundi Group Limited (ASX:EBG) is suspended from quotation as SEQ Hospitality Group acquires all issued shares under a court-approved arrangement.